Industry: Chemical & Material
Published Date: 2025-11-02
Pages: 94 Pages
Report ld: 5370907
Request Sample
Customized Report
Pharmaceutical Excipients For Injection Market Size(US$)

CAGR 2025-2031
5.6%
Market Size,2031
USD 2,445
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Pharmaceutical Excipients For Injection market size was US$ 1679 million in 2024 and is forecast to a readjusted size of US$ 2445 million by 2031 with a CAGR of 5.6% during the forecast period 2025-2031.
By 2025, the evolving U.S. tariff policy is poised to inject considerable uncertainty into the global economic landscape. This report delves into the latest U.S. tariff measures and the corresponding policy responses across the globe, evaluating their impacts on Pharmaceutical Excipients For Injection market competitiveness, regional economic performance, and supply chain configurations.
Excipients for injection refer to the general term for other ingredients other than active ingredients in sterile preparations such as injections, implants, and wound washes. Compared with other non-injectable pharmaceutical excipients, injectable pharmaceutical excipients have higher requirements on safety, quality, manufacturing equipment and packaging because they directly enter the human blood circulation through injection.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The market for pharmaceutical excipients used in injections is experiencing steady growth, fueled by ongoing innovation and expansion within the global pharmaceutical industry. The market size is continuously expanding, with increasing sales year by year. Serving as essential components of drug formulations, pharmaceutical excipients for injections play a crucial role in ensuring drug stability, enhancing efficacy, and reducing dose variability, and they find wide application across various disease treatments. With advancements in biotechnology and nanotechnology, the future of these excipients is poised to be more specialized and diverse, catering to the evolving demands of drug delivery and providing patients with safer and more effective pharmaceutical treatments.
The global Pharmaceutical Excipients For Injection market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Pharmaceutical Excipients For Injection market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Solubilizers in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Traditional Chinese Medicine Injections in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Pharmaceutical Excipients For Injection value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Pharmaceutical Excipients For Injection Product Scope
1.2 Pharmaceutical Excipients For Injection by Type
1.2.1 Global Pharmaceutical Excipients For Injection Sales by Type (2020 & 2024 & 2031)
1.2.2 Solvent
1.2.3 Solubilizers
1.2.4 pH Adjuster
1.2.5 Antioxidants
1.2.6 Others
1.3 Pharmaceutical Excipients For Injection by Application
1.3.1 Global Pharmaceutical Excipients For Injection Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Chemical Injections
1.3.3 Traditional Chinese Medicine Injections
1.3.4 Others
1.4 Global Pharmaceutical Excipients For Injection Market Estimates and Forecasts (2020-2031)
1.4.1 Global Pharmaceutical Excipients For Injection Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Pharmaceutical Excipients For Injection Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Pharmaceutical Excipients For Injection Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Pharmaceutical Excipients For Injection Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Pharmaceutical Excipients For Injection Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Pharmaceutical Excipients For Injection Sales Market Share by Region (2020-2025)
2.2.2 Global Pharmaceutical Excipients For Injection Revenue Market Share by Region (2020-2025)
2.3 Global Pharmaceutical Excipients For Injection Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Pharmaceutical Excipients For Injection Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Pharmaceutical Excipients For Injection Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Pharmaceutical Excipients For Injection Market Size and Prospective (2020-2031)
2.4.2 Europe Pharmaceutical Excipients For Injection Market Size and Prospective (2020-2031)
2.4.3 China Pharmaceutical Excipients For Injection Market Size and Prospective (2020-2031)
2.4.4 Japan Pharmaceutical Excipients For Injection Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Pharmaceutical Excipients For Injection Historic Market Review by Type (2020-2025)
3.1.1 Global Pharmaceutical Excipients For Injection Sales by Type (2020-2025)
3.1.2 Global Pharmaceutical Excipients For Injection Revenue by Type (2020-2025)
3.1.3 Global Pharmaceutical Excipients For Injection Price by Type (2020-2025)
3.2 Global Pharmaceutical Excipients For Injection Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Pharmaceutical Excipients For Injection Sales Forecast by Type (2026-2031)
3.2.2 Global Pharmaceutical Excipients For Injection Revenue Forecast by Type (2026-2031)
3.2.3 Global Pharmaceutical Excipients For Injection Price Forecast by Type (2026-2031)
3.3 Different Types Pharmaceutical Excipients For Injection Representative Players
4 Global Market Size by Application
4.1 Global Pharmaceutical Excipients For Injection Historic Market Review by Application (2020-2025)
4.1.1 Global Pharmaceutical Excipients For Injection Sales by Application (2020-2025)
4.1.2 Global Pharmaceutical Excipients For Injection Revenue by Application (2020-2025)
4.1.3 Global Pharmaceutical Excipients For Injection Price by Application (2020-2025)
4.2 Global Pharmaceutical Excipients For Injection Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Pharmaceutical Excipients For Injection Sales Forecast by Application (2026-2031)
4.2.2 Global Pharmaceutical Excipients For Injection Revenue Forecast by Application (2026-2031)
4.2.3 Global Pharmaceutical Excipients For Injection Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Pharmaceutical Excipients For Injection Application
5 Competition Landscape by Players
5.1 Global Pharmaceutical Excipients For Injection Sales by Players (2020-2025)
5.2 Global Top Pharmaceutical Excipients For Injection Players by Revenue (2020-2025)
5.3 Global Pharmaceutical Excipients For Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Excipients For Injection as of 2024)
5.4 Global Pharmaceutical Excipients For Injection Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Pharmaceutical Excipients For Injection, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Pharmaceutical Excipients For Injection, Product Type & Application
5.7 Global Key Manufacturers of Pharmaceutical Excipients For Injection, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Pharmaceutical Excipients For Injection Sales by Company
6.1.1.1 North America Pharmaceutical Excipients For Injection Sales by Company (2020-2025)
6.1.1.2 North America Pharmaceutical Excipients For Injection Revenue by Company (2020-2025)
6.1.2 North America Pharmaceutical Excipients For Injection Sales Breakdown by Type (2020-2025)
6.1.3 North America Pharmaceutical Excipients For Injection Sales Breakdown by Application (2020-2025)
6.1.4 North America Pharmaceutical Excipients For Injection Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Pharmaceutical Excipients For Injection Sales by Company
6.2.1.1 Europe Pharmaceutical Excipients For Injection Sales by Company (2020-2025)
6.2.1.2 Europe Pharmaceutical Excipients For Injection Revenue by Company (2020-2025)
6.2.2 Europe Pharmaceutical Excipients For Injection Sales Breakdown by Type (2020-2025)
6.2.3 Europe Pharmaceutical Excipients For Injection Sales Breakdown by Application (2020-2025)
6.2.4 Europe Pharmaceutical Excipients For Injection Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Pharmaceutical Excipients For Injection Sales by Company
6.3.1.1 China Pharmaceutical Excipients For Injection Sales by Company (2020-2025)
6.3.1.2 China Pharmaceutical Excipients For Injection Revenue by Company (2020-2025)
6.3.2 China Pharmaceutical Excipients For Injection Sales Breakdown by Type (2020-2025)
6.3.3 China Pharmaceutical Excipients For Injection Sales Breakdown by Application (2020-2025)
6.3.4 China Pharmaceutical Excipients For Injection Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Pharmaceutical Excipients For Injection Sales by Company
6.4.1.1 Japan Pharmaceutical Excipients For Injection Sales by Company (2020-2025)
6.4.1.2 Japan Pharmaceutical Excipients For Injection Revenue by Company (2020-2025)
6.4.2 Japan Pharmaceutical Excipients For Injection Sales Breakdown by Type (2020-2025)
6.4.3 Japan Pharmaceutical Excipients For Injection Sales Breakdown by Application (2020-2025)
6.4.4 Japan Pharmaceutical Excipients For Injection Major Customer
6.4.5 Japan Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Dow
7.1.1 Dow Company Information
7.1.2 Dow Business Overview
7.1.3 Dow Pharmaceutical Excipients For Injection Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Dow Pharmaceutical Excipients For Injection Products Offered
7.1.5 Dow Recent Development
7.2 Nippon Fine Chemical
7.2.1 Nippon Fine Chemical Company Information
7.2.2 Nippon Fine Chemical Business Overview
7.2.3 Nippon Fine Chemical Pharmaceutical Excipients For Injection Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Nippon Fine Chemical Pharmaceutical Excipients For Injection Products Offered
7.2.5 Nippon Fine Chemical Recent Development
7.3 Nanjing Well Pharmaceutical
7.3.1 Nanjing Well Pharmaceutical Company Information
7.3.2 Nanjing Well Pharmaceutical Business Overview
7.3.3 Nanjing Well Pharmaceutical Pharmaceutical Excipients For Injection Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Nanjing Well Pharmaceutical Pharmaceutical Excipients For Injection Products Offered
7.3.5 Nanjing Well Pharmaceutical Recent Development
7.4 Jiangsu Maxim Biological
7.4.1 Jiangsu Maxim Biological Company Information
7.4.2 Jiangsu Maxim Biological Business Overview
7.4.3 Jiangsu Maxim Biological Pharmaceutical Excipients For Injection Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Jiangsu Maxim Biological Pharmaceutical Excipients For Injection Products Offered
7.4.5 Jiangsu Maxim Biological Recent Development
7.5 NOF
7.5.1 NOF Company Information
7.5.2 NOF Business Overview
7.5.3 NOF Pharmaceutical Excipients For Injection Sales, Revenue and Gross Margin (2020-2025)
7.5.4 NOF Pharmaceutical Excipients For Injection Products Offered
7.5.5 NOF Recent Development
7.6 Croda
7.6.1 Croda Company Information
7.6.2 Croda Business Overview
7.6.3 Croda Pharmaceutical Excipients For Injection Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Croda Pharmaceutical Excipients For Injection Products Offered
7.6.5 Croda Recent Development
7.7 Jiangsu Poly Pharmaceutical
7.7.1 Jiangsu Poly Pharmaceutical Company Information
7.7.2 Jiangsu Poly Pharmaceutical Business Overview
7.7.3 Jiangsu Poly Pharmaceutical Pharmaceutical Excipients For Injection Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Jiangsu Poly Pharmaceutical Pharmaceutical Excipients For Injection Products Offered
7.7.5 Jiangsu Poly Pharmaceutical Recent Development
7.8 Er Kang Pharmaceutical
7.8.1 Er Kang Pharmaceutical Company Information
7.8.2 Er Kang Pharmaceutical Business Overview
7.8.3 Er Kang Pharmaceutical Pharmaceutical Excipients For Injection Sales, Revenue and Gross Margin (2020-2025)
7.8.4 Er Kang Pharmaceutical Pharmaceutical Excipients For Injection Products Offered
7.8.5 Er Kang Pharmaceutical Recent Development
7.9 Guangzhou Hanfang Pharmaceutical
7.9.1 Guangzhou Hanfang Pharmaceutical Company Information
7.9.2 Guangzhou Hanfang Pharmaceutical Business Overview
7.9.3 Guangzhou Hanfang Pharmaceutical Pharmaceutical Excipients For Injection Sales, Revenue and Gross Margin (2020-2025)
7.9.4 Guangzhou Hanfang Pharmaceutical Pharmaceutical Excipients For Injection Products Offered
7.9.5 Guangzhou Hanfang Pharmaceutical Recent Development
7.10 Pfanstiehl
7.10.1 Pfanstiehl Company Information
7.10.2 Pfanstiehl Business Overview
7.10.3 Pfanstiehl Pharmaceutical Excipients For Injection Sales, Revenue and Gross Margin (2020-2025)
7.10.4 Pfanstiehl Pharmaceutical Excipients For Injection Products Offered
7.10.5 Pfanstiehl Recent Development
7.11 Xi'an Libang Pharmaceutical
7.11.1 Xi'an Libang Pharmaceutical Company Information
7.11.2 Xi'an Libang Pharmaceutical Business Overview
7.11.3 Xi'an Libang Pharmaceutical Pharmaceutical Excipients For Injection Sales, Revenue and Gross Margin (2020-2025)
7.11.4 Xi'an Libang Pharmaceutical Pharmaceutical Excipients For Injection Products Offered
7.11.5 Xi'an Libang Pharmaceutical Recent Development
7.12 Zhejiang Tianyushan Medicinal Oil
7.12.1 Zhejiang Tianyushan Medicinal Oil Company Information
7.12.2 Zhejiang Tianyushan Medicinal Oil Business Overview
7.12.3 Zhejiang Tianyushan Medicinal Oil Pharmaceutical Excipients For Injection Sales, Revenue and Gross Margin (2020-2025)
7.12.4 Zhejiang Tianyushan Medicinal Oil Pharmaceutical Excipients For Injection Products Offered
7.12.5 Zhejiang Tianyushan Medicinal Oil Recent Development
8 Pharmaceutical Excipients For Injection Manufacturing Cost Analysis
8.1 Pharmaceutical Excipients For Injection Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Pharmaceutical Excipients For Injection
8.4 Pharmaceutical Excipients For Injection Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Pharmaceutical Excipients For Injection Distributors List
9.3 Pharmaceutical Excipients For Injection Customers
10 Pharmaceutical Excipients For Injection Market Dynamics
10.1 Pharmaceutical Excipients For Injection Industry Trends
10.2 Pharmaceutical Excipients For Injection Market Drivers
10.3 Pharmaceutical Excipients For Injection Market Challenges
10.4 Pharmaceutical Excipients For Injection Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Pharmaceutical Excipients For Injection was estimated to be worth US$ 1763 million in 2025 and is projected to reach US$ 2568 million, growing at a CAGR of 5.6% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 137
USD 3950.00
(Single User License)
The global Pharmaceutical Excipients For Injection market was valued at US$ 1763 million in 2025 and is anticipated to reach US$ 2568 million by 2032, at a CAGR of 5.6% from 2026 to 2032.
Published Date: 2026-04-18
Pages: 136
USD 2900.00
(Single User License)
The global Pharmaceutical Excipients For Injection market is projected to grow from US$ 1679 million in 2024 to US$ 2445 million by 2031, at a CAGR of 5.6% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 166
USD 4900.00
(Single User License)
The global market for Pharmaceutical Excipients For Injection was valued at US$ 1679 million in the year 2024 and is projected to reach a revised size of US$ 2445 million by 2031, growing at a CAGR of 5.6% during the forecast period.
Published Date: 2025-01-16
Pages: 104
USD 2900.00
(Single User License)
The global market for Pharmaceutical Excipients For Injection was estimated to be worth US$ 1679 million in 2024 and is forecast to a readjusted size of US$ 2445 million by 2031 with a CAGR of 5.6% during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 123
USD 3950.00
(Single User License)
Excipients for injection refer to the general term for other ingredients other than active ingredients in sterile preparations such as injections, implants, and wound washes. Compared with other non-injectable pharmaceutical excipients, injectable pharmaceutical excipients have higher requirements on safety, quality, manufacturing equipment and packaging because they directly enter the human blood circulation through injection.
Published Date: 2024-04-12
Pages: 106
USD 4900.00
(Single User License)
Excipients for injection refer to the general term for other ingredients other than active ingredients in sterile preparations such as injections, implants, and wound washes. Compared with other non-injectable pharmaceutical excipients, injectable pharmaceutical excipients have higher requirements on safety, quality, manufacturing equipment and packaging because they directly enter the human blood circulation through injection.
Published Date: 2024-01-17
Pages: 103
USD 2900.00
(Single User License)
Excipients for injection refer to the general term for other ingredients other than active ingredients in sterile preparations such as injections, implants, and wound washes. Compared with other non-injectable pharmaceutical excipients, injectable pharmaceutical excipients have higher requirements on safety, quality, manufacturing equipment and packaging because they directly enter the human blood circulation through injection.
Published Date: 2024-01-10
Pages: 124
USD 3950.00
(Single User License)
The global market for Pharmaceutical Excipients For Injection was estimated to be worth US$ 1763 million in 2025 and is projected to reach US$ 2568 million, growing at a CAGR of 5.6% from 2026 to 2032.
Published: 2026-06-16
Pages: 137
The global Pharmaceutical Excipients For Injection market was valued at US$ 1763 million in 2025 and is anticipated to reach US$ 2568 million by 2032, at a CAGR of 5.6% from 2026 to 2032.
Published: 2026-04-18
Pages: 136
The global Pharmaceutical Excipients For Injection market is projected to grow from US$ 1679 million in 2024 to US$ 2445 million by 2031, at a CAGR of 5.6% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 166
The global market for Pharmaceutical Excipients For Injection was valued at US$ 1679 million in the year 2024 and is projected to reach a revised size of US$ 2445 million by 2031, growing at a CAGR of 5.6% during the forecast period.
Published: 2025-01-16
Pages: 104
The global market for Pharmaceutical Excipients For Injection was estimated to be worth US$ 1679 million in 2024 and is forecast to a readjusted size of US$ 2445 million by 2031 with a CAGR of 5.6% during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 123
Excipients for injection refer to the general term for other ingredients other than active ingredients in sterile preparations such as injections, implants, and wound washes. Compared with other non-injectable pharmaceutical excipients, injectable pharmaceutical excipients have higher requirements on safety, quality, manufacturing equipment and packaging because they directly enter the human blood circulation through injection.
Published: 2024-04-12
Pages: 106
Excipients for injection refer to the general term for other ingredients other than active ingredients in sterile preparations such as injections, implants, and wound washes. Compared with other non-injectable pharmaceutical excipients, injectable pharmaceutical excipients have higher requirements on safety, quality, manufacturing equipment and packaging because they directly enter the human blood circulation through injection.
Published: 2024-01-17
Pages: 103
Excipients for injection refer to the general term for other ingredients other than active ingredients in sterile preparations such as injections, implants, and wound washes. Compared with other non-injectable pharmaceutical excipients, injectable pharmaceutical excipients have higher requirements on safety, quality, manufacturing equipment and packaging because they directly enter the human blood circulation through injection.
Published: 2024-01-10
Pages: 124
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now